- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
REMSleep Holdings
Market Cap: US$10.7m
A medical technology company, focuses on the development and distribution of products to help people affected by sleep apnea worldwide.
RMSL
US$0.007
7D
-30.6%
1Y
-58.6%
BetterLife Pharma
Market Cap: US$10.6m
A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.
BETR.F
US$0.081
7D
20.0%
1Y
-4.7%
Promisia Healthcare
Market Cap: NZ$17.7m
Engages in the aged care and retirement living business in New Zealand.
PHL
NZ$0.34
7D
-5.6%
1Y
n/a
Telescope Innovations
Market Cap: CA$14.5m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.27
7D
0%
1Y
-31.6%
KRTL Holding Group
Market Cap: US$10.5m
KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.
KRTL
US$0.12
7D
4.3%
1Y
2,757.1%
Cyclerion Therapeutics
Market Cap: US$10.5m
A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.
CYCN
US$3.27
7D
7.6%
1Y
10.5%
OncoSil Medical
Market Cap: AU$16.1m
A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.
OSL
AU$0.0035
7D
-12.5%
1Y
-30.0%
Firebrick Pharma
Market Cap: AU$16.1m
Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.
FRE
AU$0.071
7D
0.7%
1Y
2.1%
Hemogenyx Pharmaceuticals
Market Cap: UK£7.7m
A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.
HEMO
UK£1.77
7D
-0.4%
1Y
-70.0%
Nanollose
Market Cap: AU$15.9m
A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.
NC6
AU$0.052
7D
-8.8%
1Y
108.0%
Fusion Antibodies
Market Cap: UK£7.6m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.067
7D
-0.7%
1Y
76.3%
Pacific Health Care Organization
Market Cap: US$10.3m
Operates as a workers’ compensation cost containment company in the United States.
PFHO
US$0.80
7D
-4.6%
1Y
8.2%
NeuPath Health
Market Cap: CA$14.0m
Provides chronic pain management services in Canada.
NPTH
CA$0.25
7D
8.7%
1Y
38.9%
Minerva Neurosciences
Market Cap: US$10.2m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
NERV
US$1.46
7D
-2.7%
1Y
-40.2%
Emyria
Market Cap: AU$15.7m
Engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia.
EMD
AU$0.032
7D
-11.1%
1Y
-42.9%
SOL Global Investments
Market Cap: CA$14.0m
A private equity firm specializing in growth capital to small and mid-sized businesses.
SOL
CA$0.09
7D
-5.3%
1Y
125.0%
Inhibitor Therapeutics
Market Cap: US$10.2m
A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.
INTI
US$0.059
7D
5.2%
1Y
-45.4%
BioCardia
Market Cap: US$10.0m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$1.97
7D
-19.3%
1Y
-62.0%
Dogwood Therapeutics
Market Cap: US$10.0m
A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
DWTX
US$5.24
7D
-1.5%
1Y
0.1%
Pharmala Biotech Holdings
Market Cap: CA$13.7m
Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
MDMA
CA$0.13
7D
-7.1%
1Y
-35.0%
Aptamer Group
Market Cap: UK£7.4m
Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
APTA
UK£0.0037
7D
5.7%
1Y
-53.8%
TruScreen Group
Market Cap: NZ$16.6m
Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.
TRU
NZ$0.03
7D
7.1%
1Y
66.7%
CareView Communications
Market Cap: US$9.9m
Operates as a video monitoring solutions provider in the United States.
CRVW
US$0.017
7D
-4.5%
1Y
-67.9%
Cizzle Biotechnology Holdings
Market Cap: UK£7.3m
Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.
CIZ
UK£0.018
7D
23.3%
1Y
8.8%
Pharma-Bio Serv
Market Cap: US$9.9m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.43
7D
0%
1Y
-36.6%
Immuron
Market Cap: AU$15.2m
A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.
IMC
AU$0.065
7D
-1.5%
1Y
-30.9%
Intelligent Bio Solutions
Market Cap: US$9.7m
A medical technology company, developing rapid, non-invasive testing, and screening solutions.
INBS
US$1.41
7D
15.6%
1Y
-39.0%
ReNerve
Market Cap: AU$15.0m
A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.
RNV
AU$0.10
7D
-8.7%
1Y
n/a
RUA Life Sciences
Market Cap: UK£7.1m
Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.
RUA
UK£0.12
7D
-3.2%
1Y
-14.0%
DIH Holding US
Market Cap: US$9.7m
Operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.
DHAI
US$0.23
7D
6.5%
1Y
-85.4%
Kairos Pharma
Market Cap: US$9.6m
A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.
KAPA
US$0.57
7D
-8.2%
1Y
n/a
DH Enchantment
Market Cap: US$9.6m
Through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong.
ENMI
US$0.0025
7D
-37.5%
1Y
78.6%
Bright Green
Market Cap: US$9.6m
Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.
BGXX.Q
US$0.05
7D
-14.6%
1Y
-76.0%
HCW Biologics
Market Cap: US$9.4m
A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
HCWB
US$8.37
7D
-6.5%
1Y
-81.1%
Resverlogix
Market Cap: CA$12.8m
A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.
RVX
CA$0.045
7D
12.5%
1Y
-18.2%
Kiora Pharmaceuticals
Market Cap: US$9.3m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$3.06
7D
-5.3%
1Y
-37.7%